Clinical trial
A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of…
NCT00323102 · Bracco Diagnostics, Inc, Industry · Completed
Key facts
| NCT number | NCT00323102 |
|---|---|
| Title | A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain |
| Official title | Phase IV, Double-Blind, Multi-Center, Randomized, Cross-Over Study to Compare 0.10 Mmol/kg of MultiHance With 0.10 Omniscan in Magnetic Resonance Imaging (MRI) of the Brain |
| Acronym | ENHANCE |
| Lead sponsor | Bracco Diagnostics, Inc, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Brain Pathology |
| Intervention type | Drug |
| Interventions | Multihance |
| Enrollment | 114 |
| Start date | May 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | May 9, 2006 |
| Last update posted | Jan 23, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: